FK778

Known as: FK 778, FK-778 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2002-2012
051020022012

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
BACKGROUND BK polyomavirus infection has been reported in 10% to 60% of renal transplant recipients with progression to BK… (More)
Is this relevant?
2007
2007
The induction of transplantation tolerance involves a T-cell-mediated process of immune regulation. In clinical transplantation… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2007
2007
BACKGROUND Chronic allograft nephropathy (CAN) still belongs to the leading causes of graft loss over the long term. The… (More)
Is this relevant?
2007
2007
BACKGROUND This study examines the efficacy of FK778 regimens for prevention of different phases of xenograft rejection… (More)
Is this relevant?
2007
2007
PurposeAim of this study was to prove the efficacy and safety of the new malononitrilamide immunosuppressive FK778 in prolonging… (More)
  • figure 2
  • figure 1
  • figure 3
  • figure 4
  • figure 6
Is this relevant?
2005
2005
FK778 (Fujisawa Healthcare Inc.) is an immunosuppressant structurally similar to A771726, the active metabolite of leflunomide… (More)
Is this relevant?
2005
2005
BACKGROUND FK778 is a malononitrilamide, a class of immune suppressive compounds with antiviral features and experimental… (More)
Is this relevant?
2005
2005
BACKGROUND FK778, a derivative of the active leflunomide-metabolite, A77 1726, has been shown to be a powerful immunosuppressant… (More)
Is this relevant?
2004
2004
BACKGROUND The malononitrilamide FK778 is a novel derivate of leflunomide and interacts with T- and B-cell function by inhibiting… (More)
Is this relevant?
2003
2003
BACKGROUND FK778 is a new derivative of the active leflunomide metabolite A77 1726. It effectively prevented acute allograft… (More)
Is this relevant?